BioWorld MedTech

May 18, 2012

EuroPCR 2012: Unnerving developments in renal denervation: Product pipeline packed as competition heats up

PARIS While cardiologists play coy about their interest in taking up the new procedure for renal denervation, industry is running at full steam toward what can only be described a massive market opportunity. Read More

GE, Philips take center stage in FCC MBANs discussion

Cardiologists conflicted over role in kidney intervention

Washington roundup: Speaker proposes cost as a criterion for trial coverage

Deals roundup: CryoLife completes Hemosphere acquisition for more than $17M

Financings roundup: Zyga Technology raises $25M in a Series C funding round

Court report: Medtronic claims government has closed Infuse investigation

EuroPCR notebook: Medtronic study: CoreValve benefits men, women similarly

Agreements/contracts: 3M to open healthcare dictionary to DoD, VA

Product Briefs

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for June 15, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...

Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

BioWorld Science

Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...

Medical illustration showing layers of a blood vessel

Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis

BioWorld Science

More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...